Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals     Drug formulations    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Global Prostate Cancer Market Research Report

  • Report Code: PR 1000
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount
Prostate Cancer can be segmented by Submarkets, Geographies and Companies. Submarkets of this market are Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems (CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Chromatography Instruments, Next Generation Sequencing (NGS), Proteomics, Marketed Drugs (Prostate Cancer) and Pipeline Drugs (Prostate Cancer). Geographies of this market are Japan, India, Brazil, Russia, China, Turkey, Korea, Republic of (South Korea), Spain, Italy, USA, Canada, Germany, United Kingdom and France. Companies of this market are Sanofi-Aventis U.S., Abbott Laboratories, Dendreon Inc., AstraZeneca, Astellas Pharma Inc., Tolmar Inc. and Ipsen Group.

 

Key Questions Answered

  • What are market estimates and forecasts; which of Prostate Cancer markets are doing well and which are not?
  • What is the competitive landscape; How companies like Sanofi-Aventis U.S., Abbott Laboratories and Dendreon Inc. doing in Prostate Cancer?
  •  

    What makes our report unique?

    • This reports provides most granular segmentation on Chromatography, E-Clinical Trial Solutions, Wireless Health and Clinical Trial Management Systems (CTMS).
    • This report provides market sizing and forecast for the Prostate Cancer market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
    • The report provides deep dive competitive landscape covering the top players such as Sanofi-Aventis U.S., Abbott Laboratories, Dendreon Inc. and AstraZeneca.
    • The reports provides benchmarking insight on the top players Sanofi-Aventis U.S., Abbott Laboratories, Dendreon Inc. and AstraZeneca.
    • The report provide competitive intelligence on Sanofi-Aventis U.S., Abbott Laboratories, Dendreon Inc. and AstraZeneca.
    •  

      Audience for this report

      • Global Prostate Cancer companies
      • Manufacturing Companies
      • Traders, distributors, and suppliers
      • Governmental and research organizations
      • Associations and industry bodies
      • Technology providers


1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Submarkets
4.1 Chromatography
4.2 E-Clinical Trial Solutions
4.3 Wireless Health
4.4 Clinical Trial Management Systems (CTMS)
4.5 Healthcare IT outsourcing
4.6 Immunoassay
4.7 Digital Pathology
4.8 Chromatography Instruments
4.9 Next Generation Sequencing (NGS)
4.10 Proteomics
4.11 Marketed Drugs (Prostate Cancer)
4.12 Pipeline Drugs (Prostate Cancer)
5 By Geographies
5.1 Japan
5.2 India
5.3 Brazil
5.4 Russia
5.5 China
5.6 Turkey
5.7 Korea, Republic of (South Korea)
5.8 Spain
5.9 Italy
5.10 USA
5.11 Canada
5.12 Germany
5.13 United Kingdom
5.14 France
6 By Companies
6.1 Sanofi-Aventis U.S.
6.2 Abbott Laboratories
6.3 Dendreon Inc.
6.4 AstraZeneca
6.5 Astellas Pharma Inc.
6.6 Tolmar Inc.
6.7 Ipsen Group

Please fill in the form below to receive a free copy of the Summary of this Report
















Global Prostate Cancer Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Hormonal Therapy (Pipeline Drugs) Hormonal Therapy (Pipeline Drugs)
Hormonal Therapy (Pipeline Drugs) and its peer markets - Chromatography,
Upcoming
Targeted Therapy Targeted Therapy
Targeted Therapy and its peer markets - Immunotherapy (Pipeline Drugs),
Upcoming
Immunotherapy (Pipeline Drugs) Immunotherapy (Pipeline Drugs)
Immunotherapy (Pipeline Drugs) and its peer markets - Next Generation Sequencing (NGS),
Upcoming
Hormonal Therapy (Marketed drugs) Hormonal Therapy (Marketed drugs)
Hormonal Therapy (Marketed drugs) and its peer markets - Chemotherapy,
Upcoming
Chemotherapy Chemotherapy
Chemotherapy and its peer markets - Immunoassay, Hormonal...
Upcoming
Immunotherapy (Marketed drugs) Immunotherapy (Marketed drugs)
Immunotherapy (Marketed drugs) and its peer markets - Chromatography,
Upcoming
Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists
Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and Lutienizing Hormone-Releasing Hormone (LHRH) Analogs and
Upcoming
Lutienizing Hormone-Releasing Hormone (LHRH) Analogs Lutienizing Hormone-Releasing Hormone (LHRH) Analogs
Lutienizing Hormone-Releasing Hormone (LHRH) Analogs and Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and
Upcoming
Anti-Androgens Anti-Androgens
Anti-Androgens and Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and
Upcoming
Phase III (Immunotherapy) Phase III (Immunotherapy)
Phase III (Immunotherapy) and Phase I (Immunotherapy) and
Upcoming
Phase III (Targeted Therapy) Phase III (Targeted Therapy)
Phase III (Targeted Therapy) and Phase I (Targeted Therapy) and
Upcoming
Phase III (Hormonal Therapy) Phase III (Hormonal Therapy)
Phase III (Hormonal Therapy) and Phase I (Hormonal Therapy) and
Upcoming
12 of 12 items
12 reports | Show
Connect With Us
US/CAN : +1-888-502-0539